New research ties sustained GLP-1 use to thousands of avoided knee replacements and shows one-year persistence nearly doubling, yet employer coverage for obesity fell from 72% to 60% in a single year.
Coordinator retention is climbing back toward pre-pandemic levels, yet life sciences remains the world's most talent-scarce industry and patient dropout still runs as high as 30%, exposing a workforce problem sponsors haven't actually solved.
The pandemic exposed deep vulnerabilities in life sciences supply chains. Three years on, we assess which companies have genuinely rebuilt resilience versus which have made only cosmetic changes, and what a durable model actually requires.
Life Sciences Weekly Research
State of Life Sciences R&D Report
of CSOs say AI has already changed at least one core R&D process in their organisation, up from 31% the prior year.
HealthTech Benchmark
Digital Health Adoption Survey
Projected annual cost savings from AI-powered clinical trial optimisation across companies with pipeline assets above Phase II.
Deal Intelligence Report
Biotech M&A Pulse
Median time-to-term-sheet for sub-$500M biotech acquisitions has compressed by 9 days year-on-year as digital diligence tools reach mainstream adoption.
